ReviewChronobiology international2021
Targeting circadian PER2 as therapy in myocardial ischemia and reperfusion injury.
Yoshimasa Oyama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewChronobiology international2021
Yoshimasa Oyama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.